Release Date: 26/02/10 15:44 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 415.35KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling